Can Pilots Take Beta-Blockers and Keep FAA Medical Certification?

July 25, 2026 | FAA Medical News

Beta-Blockers and FAA Medical Certification: What Pilots Need to Know

The Ison Law Firm is based in Florida and represents pilots nationwide.

If you take beta-blockers for high blood pressure, you may still qualify for an FAA medical certificate. Beta-adrenergic blockers are explicitly listed as acceptable antihypertensive medications under FAA guidelines, and many active pilots hold medical certificates while using them. However, certification requires specific documentation, medication restrictions, and ground-trial protocols. Understanding the difference between FAA approved blood pressure medications and prohibited ones can determine whether you keep flying or face a deferral.

Reach out to the Ison Law Firm today for dedicated support. Give us a call at [(855) 598-7338](tel:855 598 7338) or contact us online to take the first step.

The Ison Law Firm is based in Florida and represents pilots nationwide.

How the FAA Regulates Blood Pressure Medication for Pilots

The FAA permits pilots who successfully control hypertension with medications, diet, or exercise to maintain medical certification. This framework applies across all three classes of medical certificates, governed by 14 CFR §67.111 (first-class), §67.211 (second-class), and §67.311 (third-class).

Under current FAA rules, pilots on three or fewer acceptable antihypertensive medications may receive a medical certificate directly from their Aviation Medical Examiner (AME) without FAA deferral, provided they are otherwise qualified and their blood pressure is within acceptable limits. Exceeding three medications or using a prohibited drug triggers a deferral and potentially requires a Special Issuance authorization under 14 CFR Part 67.

Which Beta-Blockers Does the FAA Accept?

Beta-adrenergic blockers appear on the FAA’s list of acceptable antihypertensive medications alongside ACE inhibitors, ARBs, alpha-adrenergic blockers, calcium channel blockers, direct vasodilators, and diuretics. The three most commonly prescribed beta-blockers among pilots are atenolol, metoprolol, and propranolol. However, the FAA AME Guide’s diabetes medication section lists concurrent use of a beta-blocker with meglitinides or sulfonylureas as a disqualifying combination; insulin combined with a beta-blocker is not listed as disqualifying in that section and beta-adrenergic blockers are explicitly permitted with insulin under the FAA antihypertensive guide.

Prohibited Medications: The “Do Not Issue” List

Certain centrally-acting and other specified antihypertensives will automatically disqualify you. The FAA designates the following as “Do Not Issue” medications:

• Clonidine

• Guanabenz

• Guanfacine (Tenex)

• Methyldopa

• Nitrates

• Reserpine

If your prescribing physician has placed you on any of these drugs, your AME cannot issue your medical certificate. Pilots should discuss alternative FAA-compliant medications with their treating physician before their next FAA medical examination.

💡 Pro Tip: Before scheduling your AME appointment, verify every medication against the FAA antihypertensive guide. A single prohibited medication can result in a months-long deferral.

FAA Approved Blood Pressure Medications: Acceptable vs. Prohibited at a Glance

Knowing which category your medication falls into before your AME appointment can save significant time and frustration.

This table reflects general guidance, and individual outcomes depend on the pilot’s complete medical profile. Pilots managing hypertension alongside conditions like insulin-dependent diabetes, depression, or substance dependence face additional layers of review.

💡 Pro Tip: If you take a combination pill containing two active antihypertensive agents, the FAA counts each agent separately toward the three-medication limit. Always confirm combination medication components with your pharmacist.

The Ground Trial Requirement

Every time you start a new hypertension medication, the FAA requires a no-fly ground trial period. This mandatory waiting period verifies that the new medication does not cause side effects such as dizziness, fatigue, or impaired cognitive function that could compromise safety. The FAA requires a minimum of seven days (one week) on a new antihypertensive medication before resuming flight duties, though the required period may vary.

Document your ground trial carefully. Note the start date, any side effects, and the date you resumed flying. This documentation becomes part of your aeromedical record and may prove critical if the FAA later questions your medication history.

💡 Pro Tip: Keep a written log during your ground trial including daily blood pressure readings, symptoms, and functional status. This record can support your case if the FAA or AME requests evidence of successful transition to a new medication.

What Happens When Standard Medical Requirements Are Not Met

Pilots who do not meet baseline cardiovascular standards still have a regulatory pathway to certification. Under 14 CFR §67.401, the Federal Air Surgeon may grant an Authorization for Special Issuance to a person who does not meet established medical standards, provided the pilot demonstrates the ability to perform duties without endangering public safety.

Special Issuance Conditions and Limitations

A Special Issuance authorization is not a blank check. The Federal Air Surgeon may limit the authorization’s duration, impose operational limitations, or condition continued certification on subsequent medical tests. For example, a pilot with cardiac history managing blood pressure with beta-blockers might receive a time-limited certificate requiring periodic cardiovascular evaluations.

First-class medical certificate applicants face additional electrocardiogram requirements under §67.111(b). A pilot must demonstrate the absence of myocardial infarction and other clinically significant abnormalities on an electrocardiographic examination at the first application after reaching age 35 and annually after reaching age 40.

For pilots navigating a deferral or denial related to cardiac conditions, working with a pilot medical defense attorney can help clarify documentation requirements and strengthen a Special Issuance application.

The Federal Air Surgeon’s Medication Authority

The Federal Air Surgeon holds broad discretionary power over medication evaluations under 14 CFR §67.113(c). This regulation authorizes disqualification based on any medication or other treatment, including medication effects, that the Federal Air Surgeon finds makes a pilot unable to safely perform duties. This authority applies to beta-blockers and any pharmaceutical a pilot uses, including antidepressants, ADHD medications, anti-anxiety drugs, and sleep aids.

💡 Pro Tip: If you are managing hypertension alongside a mental health condition such as depression or anxiety, coordinate with both your treating physician and an aviation medical consultant before your AME visit. The interaction between blood pressure medications and psychotropic drugs can raise additional FAA concerns requiring proactive documentation.

Real-World Risks: Beta-Blockers and Pilot Safety Data

FAA research underscores why the agency scrutinizes beta-blocker use carefully. Over a 10-year period from 1993 to 2002, the FAA’s Civil Aerospace Medical Institute identified 50 pilot fatalities involving beta-blockers: atenolol in 24 pilots, metoprolol in 19, and propranolol in 7. While these findings don’t establish that beta-blockers caused accidents, they illustrate the FAA’s ongoing interest in monitoring how these medications interact with flight operations.

This data reinforces the importance of full disclosure on FAA Form 8500-8. Failing to report a prescribed beta-blocker creates a falsification risk with consequences far more severe than a deferral. For more on managing high blood pressure and FAA certification, understanding disclosure obligations is critical.

Could an FAA Amnesty Period Change the Landscape?

Some pilots wonder whether the FAA might offer an amnesty period for those who have not fully disclosed medical conditions or medications on past applications. Such a program could potentially allow pilots to correct prior Form 8500-8 submissions without immediate enforcement action. However, no such amnesty program currently exists, and pilots should not delay proper disclosure based on speculation.

💡 Pro Tip: If you believe you made an error or omission on a past FAA medical application, consult with an attorney experienced in FAA medical certification defense before attempting to self-correct.

Frequently Asked Questions

1. Are beta-blockers considered FAA approved blood pressure medications?

Yes, beta-adrenergic blockers are listed among the FAA’s acceptable antihypertensive medications. Pilots on three or fewer total acceptable medications, including beta-blockers, may generally receive a medical certificate directly from their AME without FAA deferral.

2. Can I fly while taking beta-blockers with insulin for diabetes?

The FAA antihypertensive guide states beta-adrenergic blockers may be used with insulin, meglitinides, or sulfonylureas; however, the FAA AME Guide’s diabetes medication section lists concurrent use of a beta-blocker with meglitinides or sulfonylureas as a disqualifying combination, insulin combined with a beta-blocker is not listed as disqualifying in that section. However, insulin-dependent diabetes itself requires a Special Issuance authorization, so combined documentation requirements are more extensive.

3. What happens if my AME defers my application because of a beta-blocker?

A deferral means the AME has forwarded your application to the FAA for further review. Under 14 CFR §67.401, the Federal Air Surgeon may then grant a Special Issuance if you demonstrate you can safely perform pilot duties. This process can take weeks or months.

4. Do I need to stop flying when I switch to a new beta-blocker?

Yes, a mandatory no-fly ground trial period is required whenever you start any new hypertension medication. The FAA requires a minimum of seven days (one week) on a new antihypertensive medication before returning to flight duties. You must confirm the absence of disqualifying side effects before resuming flight duties. Of course, you should always consider your obligations under 14 C.F.R. 61.53 for self-grounding and consult with your Aviation Medical Examiner regarding safe operation.

5. Does beta-blocker use affect all classes of FAA medical certificates equally?

The cardiovascular disqualifying conditions in §67.111, §67.211, and §67.311 are substantially similar across all medical certificate classes. However, first-class applicants face additional ECG requirements after age 35 and annually after age 40 that do not apply to second- and third-class applicants.

Protecting Your Medical Certificate When Taking Beta-Blockers

Navigating FAA medical certification while managing hypertension with beta-blockers requires attention to regulatory detail, thorough documentation, and proactive communication with your AME. The FAA does allow pilots to fly on beta-blockers, but certification involves medication verification, ground trials, disclosure obligations, and potentially a Special Issuance process. Understanding the rules before your next medical examination is the most effective way to avoid preventable deferrals and protect your flying career.

If you are facing a deferral, denial, or have questions about your medication’s impact on your aviation medical certificate, the Ison Law Firm is ready to help. Call [(855) 598-7338](tel:855 598 7338) or reach out online to discuss your situation. The Ison Law Firm is based in Florida and represents pilots nationwide.